• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Pharma Sales Ops - General Discussion

Replies
3
Views
3K
anonymous
Replies
1
Views
3K
anonymous
Replies
1
Views
3K
anonymous
Replies
2
Views
4K
anonymous
Replies
1
Views
2K
anonymous
Replies
3
Views
3K
anonymous
Replies
0
Views
956
anonymous
Replies
0
Views
1K
jtgIII
Replies
1
Views
5K
anonymous
Replies
2
Views
3K
Anonymous
Replies
0
Views
2K
Anonymous
Replies
0
Views
1K
Anonymous
Replies
58
Views
27K
Anonymous
Replies
2
Views
4K
Anonymous